methyl 3-(4-(hydroxymethyl)-1H-1,2,3-triazol-1-yl)propanoate

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: methyl 3-(4-(hydroxymethyl)-1H-1,2,3-triazol-1-yl)propanoate
• 英文别名: Methyl 3-[4-(hydroxymethyl)triazol-1-yl]propanoate
• 化学式: C₇H₁₁N₃O₃
• 分子量: 185.183
• InChiKey: KSVXAJGSKIMTMZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.4
• 重原子数：
  13
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  77.2
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  methyl 3-(4-(hydroxymethyl)-1H-1,2,3-triazol-1-yl)propanoate 在 sodium azide 、 三乙胺 、 sodium hydroxide 作用下， 以 甲醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 18.0h， 生成 3-(4-(azidomethyl)-1H-1,2,3-triazol-1-yl)propanoic acid
  参考文献：
  名称：

  FRET events in fluorescent pentapeptides containing aliphatic triazolo amino acid scaffolds: Role of spacer lengths

  摘要：

  The FRET efficiencies in donor/acceptor pairs in the two termini of designed fluorescent pentapeptides depend on the flexibility of two arms of triazolyl amino acid scaffolds positioned in the center of the backbones inducing predominant beta-sheet conformations. Flexible N-Terminus of the scaffold in a pentapeptide has led to higher FRET efficiency and makes it different from other peptide with flexible C-terminus.

  DOI：

  10.1016/j.jphotochem.2019.04.024
• 作为产物：
  描述：

  azido-b-alanine methyl ester 、 2-丙炔-1-醇 在 copper(l) iodide 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 为溶剂， 以81%的产率得到methyl 3-(4-(hydroxymethyl)-1H-1,2,3-triazol-1-yl)propanoate
  参考文献：
  名称：

  FRET events in fluorescent pentapeptides containing aliphatic triazolo amino acid scaffolds: Role of spacer lengths

  摘要：

  The FRET efficiencies in donor/acceptor pairs in the two termini of designed fluorescent pentapeptides depend on the flexibility of two arms of triazolyl amino acid scaffolds positioned in the center of the backbones inducing predominant beta-sheet conformations. Flexible N-Terminus of the scaffold in a pentapeptide has led to higher FRET efficiency and makes it different from other peptide with flexible C-terminus.

  DOI：

  10.1016/j.jphotochem.2019.04.024

文献信息

• Cyclic amine derivative having heteroaryl ring
  申请人：Kimura Tomio

  公开号：US20060270706A1

  公开（公告）日：2006-11-30

  A compound having the general formula (I) wherein R 1 represents C1-C6 alkyl, etc., R 2 represents hydrogen, C2-C7 alkanoyl, C7-C11 arylcarbonyl, the formula R 4 —(CH 2 ) 1 —, etc., R 3 represents C6-C10 aryl, etc., X 1 , X 2 , X 3 , X 4 and X 5 each independently represents hydrogen, halogen, etc., and n represents an integer of 0 to 2, pharmacologically acceptable salts thereof or prodrugs thereof. They have excellent inhibition of platelet activation, etc. and are useful as a prophylactic or therapeutic agents for diseases related to thrombus or embolus formation.

  化合物具有通式（I），其中R1代表C1-C6烷基等，R2代表氢，C2-C7酰基，C7-C11芳基羰基，公式R4 -（CH2）1-等，R3代表C6-C10芳基等，X1，X2，X3，X4和X5各自独立地代表氢，卤素等，n代表0到2的整数，其药学上可接受的盐或前药。它们具有优异的抑制血小板活化等作用，并可用作与血栓或栓塞形成有关的疾病的预防或治疗剂。
• CYCLIC AMINE DERIVATIVE HAVING HETEROARYL RING
  申请人：Sankyo Company, Limited

  公开号：EP1695962A1

  公开（公告）日：2006-08-30

  A compound having the general formula (I) (wherein R1 represents C1-C6 alkyl, etc., R2 represents hydrogen, C2-C7 alkanoyl, C7-C11 arylcarbonyl, the formula R4-(CH2)1-, etc., R3 represents C6-C10 aryl, etc., X1, X2, X3, X4 and X5 each independently represents hydrogen, halogen, etc., and n represents an integer of 0 to 2), pharmacologically acceptable salts thereof or prodrugs thereof. They have excellent inhibition of platelet activation, etc. and are useful as a prophylactic or therapeutic agents for diseases related to thrombus or embolus formation.

  具有通式(I)的化合物（其中R1代表C1-C6烷基等，R2代表氢、C2-C7烷酰基、C7-C11芳羰基、式R4-(CH2)1-等，R3代表C6-C10芳基等，X1、X2、X3、X4和X5各自独立地代表氢、卤素等，n代表0至2的整数）、其药理学上可接受的盐或其原药。它们对血小板活化等有很好的抑制作用，可作为血栓或栓子形成相关疾病的预防或治疗药物。
• US7829580B2
  申请人：——

  公开号：US7829580B2

  公开（公告）日：2010-11-09